Over-the-counter availability of H2-receptor antagonists and gastric cancer [3]

Annals of Internal Medicine

Volumn 133, Issue 8, 2000, Pages 659-

  Yoshikawa, I ^a   Murata, I ^a   Otsuki, M ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; NON PRESCRIPTION DRUG;

ADENOCARCINOMA; ADULT; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DOSE RESPONSE; DRUG LABELING; EARLY DIAGNOSIS; ENDOSCOPY; HUMAN; LETTER; MALE; PARTIAL GASTRECTOMY; PRESCRIPTION; PRIORITY JOURNAL; SELF EVALUATION; SELF MEDICATION; STOMACH CARCINOMA; STOMACH ULCER; MIDDLE AGED; SELF CARE; STOMACH TUMOR; TIME;

DRUGS, NON-PRESCRIPTION; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; SELF CARE; STOMACH NEOPLASMS; STOMACH ULCER; TIME FACTORS;

EID: 0034680266     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-133-8-200010170-00026     Document Type: Letter

References (2)

1. Misleading response of malignant gastric ulcers to cimetidine
2. The risks and benefits of an RRx-to-OTC switch. The case of over-the-counter H2-blockers